Home » ‘Medical Malpractice’: The Glaring Red Flags Abortion Activists Ignore

‘Medical Malpractice’: The Glaring Red Flags Abortion Activists Ignore

This post was originally published on this site.

Despite countless red flags, leftist activists continue to send out abortion pills indiscriminately all across the country.  An investigation shared with The Daily Wire by the American Association of Pro-Life OB/GYNs found that activist group Aid Access shipped pills to an investigator from the group posing as a 13-year-old girl who had three prior C-section …

Despite countless red flags, leftist activists continue to send out abortion pills indiscriminately all across the country. 

An investigation shared with The Daily Wire by the American Association of Pro-Life OB/GYNs found that activist group Aid Access shipped pills to an investigator from the group posing as a 13-year-old girl who had three prior C-section births. The pills arrived in Indiana after investigator Dr. Christina Francis ordered the pills for a patient with a complicated medical history to see how the organization would respond. 

“What this investigation uncovered is far from anything that could be called healthcare,” the American Association of Pro-Life OB/GYNs (AAPLOG) wrote in a letter obtained by The Daily Wire Thursday, sent to top Republican lawmakers. “In fact, it should be considered medical malpractice.”

Restrictions around the mailing of the abortion pill mifepristone were loosened during the Biden administration, meaning pills can be sent out without an in-person appointment. That decision, still in place, occurred as abortion via pill cemented itself as the most common method to end the life of an unborn child. Pro-life activists have urged the Food and Drug Administration to reinstate those guidelines. 

While filling out an Aid Access pill intake form, Francis listed several conditions, including being on blood thinners, having an intrauterine device, and a history of ectopic pregnancy. Those conditions did not deter Aid Access, and pills arrived four days after Francis ordered them. 

Francis found that Aid Access sent her the pills with no identity verification, confirmation of pregnancy, or any medical consultation despite claims on its website that it would have a medical professional review a medical questionnaire answered by those looking for pills. 

“To test the level of medical review and due diligence, we intentionally put red flags in our answers with several contraindications so ridiculous any one of them should have been a hard stop for a physician conducting an in-person screening and informed consent. However, we were shockingly allowed to complete the process,” AAPLOG told lawmakers. 

Within minutes of filling out her form, Francis received a follow-up email with payment information and no indication that anyone had reviewed the medical information. 

“The intake process did not include a live consultation with a medical professional (such as what would happen with a telehealth visit). Even an asynchronous review of the user’s health information did not occur as the payment link was emailed less than 2 minutes after request submitted,” the investigation found. 

The pills were sent from a generic address in California to Indiana, where medication abortions are technically against the law. Aid Access, which says it ships abortion pills into all 50 states, did not respond to a request for comment. 

AAPLOG warned that the process enabled young children to easily access the deadly pills as well as those who might want to secretly coerce abortions. Several men across the country have been charged with forced abortions via abortion pills they ordered online. 

The investigation was sent Thursday to Senator Bill Cassidy (R-LA), the chair of the Senate Health, Education, Labor, and Pensions Committee, as well as Senator Mike Crapo (R-ID), Rep. Brett Guthrie (R-KY), and Rep. James Comer (R-KY). 

AAPLOG urged them to use their “power and purview to restore common sense and basic safeguards for abortion pill distribution as a first step to protect our maternal and fetal patients.”